Alison Lawton
Director/Board Member at DIANTHUS THERAPEUTICS, INC.
Net worth: 58 384 $ as of 30/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Paula Ragan | M | 54 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 16 years |
| Theresa Heggie | F | 63 | 1 years | |
| David McGirr | M | 69 | 20 years | |
| Daniel Calkins | M | 37 | 6 years | |
| Michael Wyzga | M | 69 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 20 years |
| Tomas Kiselak | M | 38 | 1 years | |
| Gerard J. Platenburg | M | 60 | 12 years | |
| Theo Melas-Kyriazi | M | 64 | 5 years | |
| Marino Garcia | M | 57 | 1 years | |
| Daniel de Boer | M | 41 | 12 years | |
| Brian Stuglik | M | 64 | 7 years | |
| Adam Mostafa | M | 44 | 6 years | |
| Eric R. Ward | M | - |
AgBiome INC
 AgBiome INC BiotechnologyHealth Technology AgBiome LLC provides early stage research and discovery to the agriculture industry. It develops biological product that controls the predominant soil-borne diseases of greenhouse and major row crops. The firm applies genomics and screening technologies to identify plant-associated microbes that enhance plant health, pest resistance, and yield. The company was founded by Jeff Dangl, John N. Couch, Paul Schulze-Lefert, Scott J. Uknes, John Ryals, Eric R. Ward, and Mike Koziel in 2012 and is headquartered in Research Triangle Park, NC. | 12 years |
| Scott J. Uknes | M | - |
AgBiome INC
AgBiome INC BiotechnologyHealth Technology AgBiome LLC provides early stage research and discovery to the agriculture industry. It develops biological product that controls the predominant soil-borne diseases of greenhouse and major row crops. The firm applies genomics and screening technologies to identify plant-associated microbes that enhance plant health, pest resistance, and yield. The company was founded by Jeff Dangl, John N. Couch, Paul Schulze-Lefert, Scott J. Uknes, John Ryals, Eric R. Ward, and Mike Koziel in 2012 and is headquartered in Research Triangle Park, NC. | 12 years |
| Gary Bridger | M | 61 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 8 years |
| Michael Kauffman | M | 60 | 12 years | |
| Cameron Turtle | M | 34 | 1 years | |
| René Beukema | M | 60 | 8 years | |
| Mary DiBiase | M | 63 | 7 years | |
| Paula Soteropoulos | F | 56 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 23 years |
| Michael Henderson | M | 34 | 1 years | |
| Rachel Lynn Salzman | M | 65 |
SwanBio Therapeutics, Inc.
 SwanBio Therapeutics, Inc. BiotechnologyHealth Technology SwanBio Therapeutics, Inc. operates as a gene therapy firm. The company was founded by Tom Anderson, Rachel Salzman, Karen Kozarsky and Florian S. Eichler and is headquartered in Bala Cynwyd, PA. | - |
| John Tsai | M | 57 |
SwanBio Therapeutics, Inc.
SwanBio Therapeutics, Inc. BiotechnologyHealth Technology SwanBio Therapeutics, Inc. operates as a gene therapy firm. The company was founded by Tom Anderson, Rachel Salzman, Karen Kozarsky and Florian S. Eichler and is headquartered in Bala Cynwyd, PA. | 1 years |
| Murray Stewart | M | 63 | 5 years | |
| Françoise de Craecker | F | 62 | 3 years | |
| Heidy Abreu King-Jones | F | 41 | 1 years | |
| Adam Veness | M | 38 | 1 years | |
| Scott Burrows | M | 47 | 1 years | |
| Sheila Sponselee | F | - | 4 years | |
| Peter Harwin | M | 38 | 1 years | |
| Karen F. Kozarsky | M | - |
SwanBio Therapeutics, Inc.
SwanBio Therapeutics, Inc. BiotechnologyHealth Technology SwanBio Therapeutics, Inc. operates as a gene therapy firm. The company was founded by Tom Anderson, Rachel Salzman, Karen Kozarsky and Florian S. Eichler and is headquartered in Bala Cynwyd, PA. | - |
| Anne McGeorge | F | 63 | 1 years | |
| Brian M. Baynes | M | - |
Cadena Bio, Inc.
 Cadena Bio, Inc. Pharmaceuticals: OtherHealth Technology Cadena Bio, Inc. engages in the manufacture of supplements for human health and nutrition by feeding the microbiome. The company was founded in 2016 and is headquartered in Lexington, MA. | 4 years |
| Eric Rowinsky | M | 67 | 7 years | |
| John Johnson | M | 66 | 4 years | |
| John A. Ryals | M | - |
AgBiome INC
AgBiome INC BiotechnologyHealth Technology AgBiome LLC provides early stage research and discovery to the agriculture industry. It develops biological product that controls the predominant soil-borne diseases of greenhouse and major row crops. The firm applies genomics and screening technologies to identify plant-associated microbes that enhance plant health, pest resistance, and yield. The company was founded by Jeff Dangl, John N. Couch, Paul Schulze-Lefert, Scott J. Uknes, John Ryals, Eric R. Ward, and Mike Koziel in 2012 and is headquartered in Research Triangle Park, NC. | 12 years |
| Lonnie Moulder | M | 66 | 1 years | |
| Raj Bhikhu Parekh | M | 63 | 9 years | |
| Domenico Valerio | M | 67 | 12 years | |
| Jeffrey Albers | M | 52 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 8 years |
| Michael Gene Koziel | M | - |
AgBiome INC
AgBiome INC BiotechnologyHealth Technology AgBiome LLC provides early stage research and discovery to the agriculture industry. It develops biological product that controls the predominant soil-borne diseases of greenhouse and major row crops. The firm applies genomics and screening technologies to identify plant-associated microbes that enhance plant health, pest resistance, and yield. The company was founded by Jeff Dangl, John N. Couch, Paul Schulze-Lefert, Scott J. Uknes, John Ryals, Eric R. Ward, and Mike Koziel in 2012 and is headquartered in Research Triangle Park, NC. | 12 years |
| Amir Nashat | M | 51 |
AgBiome INC
AgBiome INC BiotechnologyHealth Technology AgBiome LLC provides early stage research and discovery to the agriculture industry. It develops biological product that controls the predominant soil-borne diseases of greenhouse and major row crops. The firm applies genomics and screening technologies to identify plant-associated microbes that enhance plant health, pest resistance, and yield. The company was founded by Jeff Dangl, John N. Couch, Paul Schulze-Lefert, Scott J. Uknes, John Ryals, Eric R. Ward, and Mike Koziel in 2012 and is headquartered in Research Triangle Park, NC. | 11 years |
| Bill Aliski | M | 75 | 5 years | |
| Jean K. Mixer | F | 57 | 5 years | |
| James Shannon | M | 67 | 8 years | |
| Bart Filius | M | 53 | 5 years | |
| Lei Meng | F | 52 | 1 years | |
| Jonathan Violin | M | 49 | 1 years | |
| Simrat Randhawa | M | 56 | 1 years | |
| Debra Segal | F | - | 1 years | |
| Brian Connolly | M | - | 1 years | |
| Mira Huyghe | F | - | 1 years | |
| Joshua Friedman | M | - | 1 years | |
| Douangsone Vadysirisack | M | - | 1 years | |
| Angela Norton | M | - | 1 years | |
| Christopher Brooke | M | - |
SwanBio Therapeutics, Inc.
SwanBio Therapeutics, Inc. BiotechnologyHealth Technology SwanBio Therapeutics, Inc. operates as a gene therapy firm. The company was founded by Tom Anderson, Rachel Salzman, Karen Kozarsky and Florian S. Eichler and is headquartered in Bala Cynwyd, PA. | 1 years |
| Begoña Carreño | M | 52 | 1 years | |
| Mark Mckenna | M | 48 | - | |
| Nilay Thakar | M | - |
AgBiome INC
AgBiome INC BiotechnologyHealth Technology AgBiome LLC provides early stage research and discovery to the agriculture industry. It develops biological product that controls the predominant soil-borne diseases of greenhouse and major row crops. The firm applies genomics and screening technologies to identify plant-associated microbes that enhance plant health, pest resistance, and yield. The company was founded by Jeff Dangl, John N. Couch, Paul Schulze-Lefert, Scott J. Uknes, John Ryals, Eric R. Ward, and Mike Koziel in 2012 and is headquartered in Research Triangle Park, NC. | 2 years |
| Krysta Harden | F | 65 |
AgBiome INC
AgBiome INC BiotechnologyHealth Technology AgBiome LLC provides early stage research and discovery to the agriculture industry. It develops biological product that controls the predominant soil-borne diseases of greenhouse and major row crops. The firm applies genomics and screening technologies to identify plant-associated microbes that enhance plant health, pest resistance, and yield. The company was founded by Jeff Dangl, John N. Couch, Paul Schulze-Lefert, Scott J. Uknes, John Ryals, Eric R. Ward, and Mike Koziel in 2012 and is headquartered in Research Triangle Park, NC. | 3 years |
| Sarah Kiely | F | - | 5 years | |
| Kristina Maximenko | F | - | 1 years | |
| Paul Fehlner | M | 61 | 1 years | |
| Jeffrey Stavenhagen | M | - | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Henri A. Termeer | M | 78 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 34 years |
| Jerald Korn | M | 45 | 6 years | |
| Robert M. Forrester | M | 60 | 8 years | |
| David Meeker | M | 69 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 23 years |
| Jonathan Alspaugh | M | 41 | - | |
| Paul Brannelly | M | 51 | 3 years | |
| Jim Kastenmayer | M | 52 | 2 years | |
| Joseph Chiapponi | M | 55 | 6 years | |
| René Russo | M | 49 | 6 years | |
| Harald F. Stock | M | 56 |
OvaScience, Inc.
 OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | 3 years |
| Anthony Quinn | M | 62 | 6 years | |
| Thomas DesRosier | M | 69 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 15 years |
| Christopher Viehbacher | M | 64 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
| Julie Feder | F | 54 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 1 years |
| Peter Wirth | M | 73 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 20 years |
| Jeffrey Goldberg | M | 51 | 1 years | |
| William Duke | M | 51 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 5 years |
| Jonathan L. Tilly | M | 61 |
OvaScience, Inc.
OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | 3 years |
| Michael Gray | M | 53 | 3 years | |
| Christoph H. Westphal | M | 56 |
OvaScience, Inc.
OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | 3 years |
| Christopher M. Lindblom | M | 52 |
OvaScience, Inc.
OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | - |
| Armen Shanafelt | M | 64 | 10 years | |
| Daniel L. Menichella | M | 64 | 2 years | |
| Richard H. Aldrich | M | 69 | 4 years | |
| Charles York | M | 47 | 7 years | |
| Derek Meisner | M | 53 | 3 years | |
| Sariette Witte | F | - | 8 years | |
| Timothy Barberich | M | 76 | 8 years | |
| Brian Sullivan | M | - | 9 years | |
| Smital Shah | F | 48 | 8 years | |
| Cortney Caudill | F | - | 4 years | |
| Amy Ronneberg | F | 49 | - | |
| Thomas Anderson | M | 68 |
SwanBio Therapeutics, Inc.
SwanBio Therapeutics, Inc. BiotechnologyHealth Technology SwanBio Therapeutics, Inc. operates as a gene therapy firm. The company was founded by Tom Anderson, Rachel Salzman, Karen Kozarsky and Florian S. Eichler and is headquartered in Bala Cynwyd, PA. | 4 years |
| Patrick Volkert Vink | M | 60 | 3 years | |
| Tamara Joseph | F | 61 | 4 years | |
| Bruce Wendel | M | 70 | 5 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 88 | 88.00% |
| Netherlands | 13 | 13.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Alison Lawton
- Personal Network